1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Generic Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Prescription
1.2.3 Non-Prescription Drugs
1.3 Market by Application
1.3.1 Global Generic Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Generic Drugs Market Perspective (2016-2027)
2.2 Generic Drugs Growth Trends by Regions
2.2.1 Generic Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Generic Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Generic Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Generic Drugs Industry Dynamic
2.3.1 Generic Drugs Market Trends
2.3.2 Generic Drugs Market Drivers
2.3.3 Generic Drugs Market Challenges
2.3.4 Generic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Generic Drugs Players by Revenue
3.1.1 Global Top Generic Drugs Players by Revenue (2016-2021)
3.1.2 Global Generic Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Generic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Generic Drugs Revenue
3.4 Global Generic Drugs Market Concentration Ratio
3.4.1 Global Generic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Generic Drugs Revenue in 2020
3.5 Generic Drugs Key Players Head office and Area Served
3.6 Key Players Generic Drugs Product Solution and Service
3.7 Date of Enter into Generic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Generic Drugs Breakdown Data by Type
4.1 Global Generic Drugs Historic Market Size by Type (2016-2021)
4.2 Global Generic Drugs Forecasted Market Size by Type (2022-2027)
5 Generic Drugs Breakdown Data by Application
5.1 Global Generic Drugs Historic Market Size by Application (2016-2021)
5.2 Global Generic Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Generic Drugs Market Size (2016-2027)
6.2 North America Generic Drugs Market Size by Type
6.2.1 North America Generic Drugs Market Size by Type (2016-2021)
6.2.2 North America Generic Drugs Market Size by Type (2022-2027)
6.2.3 North America Generic Drugs Market Size by Type (2016-2027)
6.3 North America Generic Drugs Market Size by Application
6.3.1 North America Generic Drugs Market Size by Application (2016-2021)
6.3.2 North America Generic Drugs Market Size by Application (2022-2027)
6.3.3 North America Generic Drugs Market Size by Application (2016-2027)
6.4 North America Generic Drugs Market Size by Country
6.4.1 North America Generic Drugs Market Size by Country (2016-2021)
6.4.2 North America Generic Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Generic Drugs Market Size (2016-2027)
7.2 Europe Generic Drugs Market Size by Type
7.2.1 Europe Generic Drugs Market Size by Type (2016-2021)
7.2.2 Europe Generic Drugs Market Size by Type (2022-2027)
7.2.3 Europe Generic Drugs Market Size by Type (2016-2027)
7.3 Europe Generic Drugs Market Size by Application
7.3.1 Europe Generic Drugs Market Size by Application (2016-2021)
7.3.2 Europe Generic Drugs Market Size by Application (2022-2027)
7.3.3 Europe Generic Drugs Market Size by Application (2016-2027)
7.4 Europe Generic Drugs Market Size by Country
7.4.1 Europe Generic Drugs Market Size by Country (2016-2021)
7.4.2 Europe Generic Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Generic Drugs Market Size (2016-2027)
8.2 Asia-Pacific Generic Drugs Market Size by Type
8.2.1 Asia-Pacific Generic Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Generic Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Generic Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Generic Drugs Market Size by Application
8.3.1 Asia-Pacific Generic Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Generic Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Generic Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Generic Drugs Market Size by Region
8.4.1 Asia-Pacific Generic Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Generic Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Generic Drugs Market Size (2016-2027)
9.2 Latin America Generic Drugs Market Size by Type
9.2.1 Latin America Generic Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Generic Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Generic Drugs Market Size by Type (2016-2027)
9.3 Latin America Generic Drugs Market Size by Application
9.3.1 Latin America Generic Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Generic Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Generic Drugs Market Size by Application (2016-2027)
9.4 Latin America Generic Drugs Market Size by Country
9.4.1 Latin America Generic Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Generic Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Generic Drugs Market Size (2016-2027)
10.2 Middle East & Africa Generic Drugs Market Size by Type
10.2.1 Middle East & Africa Generic Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Generic Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Generic Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Generic Drugs Market Size by Application
10.3.1 Middle East & Africa Generic Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Generic Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Generic Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Generic Drugs Market Size by Country
10.4.1 Middle East & Africa Generic Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Generic Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Teva Business Overview
11.1.3 Teva Generic Drugs Introduction
11.1.4 Teva Revenue in Generic Drugs Business (2016-2021)
11.1.5 Teva Recent Development
11.2 Novartis - Sandoz
11.2.1 Novartis - Sandoz Company Details
11.2.2 Novartis - Sandoz Business Overview
11.2.3 Novartis - Sandoz Generic Drugs Introduction
11.2.4 Novartis - Sandoz Revenue in Generic Drugs Business (2016-2021)
11.2.5 Novartis - Sandoz Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Generic Drugs Introduction
11.3.4 Mylan Revenue in Generic Drugs Business (2016-2021)
11.3.5 Mylan Recent Development
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Details
11.4.2 Sun Pharmaceutical Business Overview
11.4.3 Sun Pharmaceutical Generic Drugs Introduction
11.4.4 Sun Pharmaceutical Revenue in Generic Drugs Business (2016-2021)
11.4.5 Sun Pharmaceutical Recent Development
11.5 Aspen
11.5.1 Aspen Company Details
11.5.2 Aspen Business Overview
11.5.3 Aspen Generic Drugs Introduction
11.5.4 Aspen Revenue in Generic Drugs Business (2016-2021)
11.5.5 Aspen Recent Development
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Details
11.6.2 Fresenius Kabi Business Overview
11.6.3 Fresenius Kabi Generic Drugs Introduction
11.6.4 Fresenius Kabi Revenue in Generic Drugs Business (2016-2021)
11.6.5 Fresenius Kabi Recent Development
11.7 Pfizer (Hospira)
11.7.1 Pfizer (Hospira) Company Details
11.7.2 Pfizer (Hospira) Business Overview
11.7.3 Pfizer (Hospira) Generic Drugs Introduction
11.7.4 Pfizer (Hospira) Revenue in Generic Drugs Business (2016-2021)
11.7.5 Pfizer (Hospira) Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Generic Drugs Introduction
11.8.4 Sanofi Revenue in Generic Drugs Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 Aurobindo
11.9.1 Aurobindo Company Details
11.9.2 Aurobindo Business Overview
11.9.3 Aurobindo Generic Drugs Introduction
11.9.4 Aurobindo Revenue in Generic Drugs Business (2016-2021)
11.9.5 Aurobindo Recent Development
11.10 Lupin
11.10.1 Lupin Company Details
11.10.2 Lupin Business Overview
11.10.3 Lupin Generic Drugs Introduction
11.10.4 Lupin Revenue in Generic Drugs Business (2016-2021)
11.10.5 Lupin Recent Development
11.11 Dr. Reddy's
11.11.1 Dr. Reddy's Company Details
11.11.2 Dr. Reddy's Business Overview
11.11.3 Dr. Reddy's Generic Drugs Introduction
11.11.4 Dr. Reddy's Revenue in Generic Drugs Business (2016-2021)
11.11.5 Dr. Reddy's Recent Development
11.12 Apotex
11.12.1 Apotex Company Details
11.12.2 Apotex Business Overview
11.12.3 Apotex Generic Drugs Introduction
11.12.4 Apotex Revenue in Generic Drugs Business (2016-2021)
11.12.5 Apotex Recent Development
11.13 Cipla
11.13.1 Cipla Company Details
11.13.2 Cipla Business Overview
11.13.3 Cipla Generic Drugs Introduction
11.13.4 Cipla Revenue in Generic Drugs Business (2016-2021)
11.13.5 Cipla Recent Development
11.14 ENDO (Par Pharmaceutical)
11.14.1 ENDO (Par Pharmaceutical) Company Details
11.14.2 ENDO (Par Pharmaceutical) Business Overview
11.14.3 ENDO (Par Pharmaceutical) Generic Drugs Introduction
11.14.4 ENDO (Par Pharmaceutical) Revenue in Generic Drugs Business (2016-2021)
11.14.5 ENDO (Par Pharmaceutical) Recent Development
11.15 Stada Arzneimittel
11.15.1 Stada Arzneimittel Company Details
11.15.2 Stada Arzneimittel Business Overview
11.15.3 Stada Arzneimittel Generic Drugs Introduction
11.15.4 Stada Arzneimittel Revenue in Generic Drugs Business (2016-2021)
11.15.5 Stada Arzneimittel Recent Development
11.16 Krka Group
11.16.1 Krka Group Company Details
11.16.2 Krka Group Business Overview
11.16.3 Krka Group Generic Drugs Introduction
11.16.4 Krka Group Revenue in Generic Drugs Business (2016-2021)
11.16.5 Krka Group Recent Development
11.17 Nichi-Iko Pharmaceutical
11.17.1 Nichi-Iko Pharmaceutical Company Details
11.17.2 Nichi-Iko Pharmaceutical Business Overview
11.17.3 Nichi-Iko Pharmaceutical Generic Drugs Introduction
11.17.4 Nichi-Iko Pharmaceutical Revenue in Generic Drugs Business (2016-2021)
11.17.5 Nichi-Iko Pharmaceutical Recent Development
11.18 Valeant
11.18.1 Valeant Company Details
11.18.2 Valeant Business Overview
11.18.3 Valeant Generic Drugs Introduction
11.18.4 Valeant Revenue in Generic Drugs Business (2016-2021)
11.18.5 Valeant Recent Development
11.19 Zydus Cadila
11.19.1 Zydus Cadila Company Details
11.19.2 Zydus Cadila Business Overview
11.19.3 Zydus Cadila Generic Drugs Introduction
11.19.4 Zydus Cadila Revenue in Generic Drugs Business (2016-2021)
11.19.5 Zydus Cadila Recent Development
11.20 Hikma
11.20.1 Hikma Company Details
11.20.2 Hikma Business Overview
11.20.3 Hikma Generic Drugs Introduction
11.20.4 Hikma Revenue in Generic Drugs Business (2016-2021)
11.20.5 Hikma Recent Development
11.21 Pharmaniaga Berhad
11.21.1 Pharmaniaga Berhad Company Details
11.21.2 Pharmaniaga Berhad Business Overview
11.21.3 Pharmaniaga Berhad Generic Drugs Introduction
11.21.4 Pharmaniaga Berhad Revenue in Generic Drugs Business (2016-2021)
11.21.5 Pharmaniaga Berhad Recent Development
11.22 Hovid Berhad
11.22.1 Hovid Berhad Company Details
11.22.2 Hovid Berhad Business Overview
11.22.3 Hovid Berhad Generic Drugs Introduction
11.22.4 Hovid Berhad Revenue in Generic Drugs Business (2016-2021)
11.22.5 Hovid Berhad Recent Development
11.23 Duopharma Biotech
11.23.1 Duopharma Biotech Company Details
11.23.2 Duopharma Biotech Business Overview
11.23.3 Duopharma Biotech Generic Drugs Introduction
11.23.4 Duopharma Biotech Revenue in Generic Drugs Business (2016-2021)
11.23.5 Duopharma Biotech Recent Development
11.24 Kotra Pharma
11.24.1 Kotra Pharma Company Details
11.24.2 Kotra Pharma Business Overview
11.24.3 Kotra Pharma Generic Drugs Introduction
11.24.4 Kotra Pharma Revenue in Generic Drugs Business (2016-2021)
11.24.5 Kotra Pharma Recent Development
11.25 HOE Pharmaceutical
11.25.1 HOE Pharmaceutical Company Details
11.25.2 HOE Pharmaceutical Business Overview
11.25.3 HOE Pharmaceutical Generic Drugs Introduction
11.25.4 HOE Pharmaceutical Revenue in Generic Drugs Business (2016-2021)
11.25.5 HOE Pharmaceutical Recent Development
11.26 Y.S.P. Industries
11.26.1 Y.S.P. Industries Company Details
11.26.2 Y.S.P. Industries Business Overview
11.26.3 Y.S.P. Industries Generic Drugs Introduction
11.26.4 Y.S.P. Industries Revenue in Generic Drugs Business (2016-2021)
11.26.5 Y.S.P. Industries Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
